Seven Fleet Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Seven Fleet Capital Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-128,487	Closed	-$2.59M	–	105
2026 Q1	$2.59M	Buy	128,487 +80,075	+165%	+$1.29M	0.81%	33
2025 Q4	$782K	Buy	+48,412	New	+$641K	0.53%	36

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Seven Fleet Capital Management's KALV Position: Q2 2026 in Review

Seven Fleet Capital Management sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 128,487 shares — an estimated $2.59M sold.

Seven Fleet Capital Management first reported a position in KALV in Q4 2025 and held it in 2 quarters. The position peaked at $2.59M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Seven Fleet Capital Management reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Seven Fleet Capital Management sold 128,487 KalVista Pharmaceuticals shares in Q2 2026, an estimated $2.59M.
Seven Fleet Capital Management first reported a position in KalVista Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Seven Fleet Capital Management's KalVista Pharmaceuticals position peaked at $2.59M in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.